Park Place Capital’s Dyne Therapeutics DYN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-47
Closed -$852 – 393
2026
Q1
$852 Buy
+47
New +$810 ﹤0.01% 814

Other funds holding DYN

Park Place Capital's DYN Position: Q2 2026 in Review

Park Place Capital sold out of Dyne Therapeutics (DYN) in Q2 2026, closing a stake of 47 shares — an estimated $852 sold.

Park Place Capital first reported a position in DYN in Q1 2026 and held it in 1 quarter. The position peaked at $852 in Q1 2026. 246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Park Place Capital reported no remaining Dyne Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Park Place Capital sold 47 Dyne Therapeutics shares in Q2 2026, an estimated $852.
  • Park Place Capital first reported a position in Dyne Therapeutics in Q1 2026 and held it in 1 quarter.
  • Park Place Capital's Dyne Therapeutics position peaked at $852 in Q1 2026.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.